← Back to Patent Explorer
US5965408A Expired / Lapsed US ⏱️ 0.0 years remaining

Method of DNA reassembly by interrupting synthesis

Assignee: BP Corp North America Inc
•
Filing: 1996-07-09
•
Granted: 1999-10-12
•
Expires: 2016-07-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Disclosed is a process of performing Sexual PCR which includes generating random polynucleotides by interrupting or blocking a synthesis or amplification process to show or halt synthesis or amplification of at least one polynucleotide, optionally amplifying the polynucleotides, and reannealing the polynucleotides to produce random mutant polynucleotides. Also provided are vector and expression vehicles including such mutant polynucleotides, polypeptides expressed by the mutant polynucleotides and a method for producing random mutant polypeptides.

Inventors

  • 👤 Jay M. Short

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 20:05
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6811; C12N; C12N15/00; C12N15/09; C12N15/10; C12N15/102; C12N15/1027

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 243 words
An in vitro method for producing polynucleotides comprising: a) contacting a heterogenous, single-stranded DNA population containing complementary single-stranded DNA from at least one gene, wherein said single-stranded DNA is obtained by separating double-stranded DNA from at least one gene into two single strands, with one or more random oligonucleotide primers under conditions which allow annealing of the primers to the single-stranded heterogeneous DNA population; b) incubating the DNA of a) with a polymerase under conditions sufficient for DNA synthesis; c) contacting the DNA population with a means for interrupting polynucleotide synthesis, thereby resulting in synthesis of partially double-stranded DNA fragments; d) denaturing the resulting partially double-stranded DNA to produce a mixture of single-stranded DNA sequences, optionally separating the single-stranded DNA sequences into pools of single-stranded DNA sequences having various lengths, and further optionally subjecting the pools of single-stranded DNA sequences to a priming and amplification procedure to amplify one or more single-stranded sequences comprised of at least one of the pools of single-stranded DNA sequences; e) incubating a plurality of the single-stranded DNA sequences or at least one pool of the single-stranded DNA sequences under conditions which promote annealing of the single-stranded DNA sequences to other single-stranded DNA sequences at regions of shared homology and under conditions which promote synthesis of double-stranded DNA sequences, thereby resulting in double-stranded polynucleotides; and f) repeating b) through e) at least one time, wherein the double-stranded polynucleotides from e) are denatured prior to repeating b) through e).
Claim 2
Dependent Claim 243 words
An in vitro method for producing polynucleotides comprising: a) contacting a heterogenous, single-stranded DNA population containing complementary single-stranded DNA from at least one gene, wherein said single-stranded DNA is obtained by separating double-stranded DNA from at least one gene into two single strands, with one or more random oligonucleotide primers under conditions which allow annealing of the primers to the single-stranded heterogeneous DNA population; b) incubating the DNA of a) with a polymerase under conditions sufficient for DNA synthesis; c) contacting the DNA population with a means for interrupting polynucleotide synthesis, thereby resulting in synthesis of partially double-stranded DNA fragments; d) denaturing the resulting partially double-stranded DNA to produce a mixture of single-stranded DNA sequences, optionally separating the single-stranded DNA sequences into pools of single-stranded DNA sequences having various lengths, and further optionally subjecting the pools of single-stranded DNA sequences to a priming and amplification procedure to amplify one or more single-stranded sequences comprised of at least one of the pools of single-stranded DNA sequences; e) incubating a plurality of the single-stranded DNA sequences or at least one pool of the single-stranded DNA sequences under conditions which promote annealing of the single-stranded DNA sequences to other single-stranded DNA sequences at regions of shared homology and under conditions which promote synthesis of double-stranded DNA sequences, thereby resulting in double-stranded polynucleotides; and f) repeating b) through e) at least one time, wherein the double-stranded polynucleotides from e) are denatured prior to repeating b) through e).
Claim 3
Dependent Claim 24 words
The method of claim 1, wherein the DNA population is contacted with a means for interrupting polynucleotide synthesis prior to or during part a).
Claim 4
Dependent Claim 24 words
The method of claim 1, wherein the DNA population is contacted with a means for interrupting polynucleotide synthesis prior to or during part b).
Claim 5
Dependent Claim 11 words
The method of claim 1, wherein the polynucleotide encodes an enzyme.
Claim 6
Dependent Claim 22 words
The method of claim 4, wherein the enzyme is selected from the group consisting of oxidoreductase, transferase, hydrolase, lyase, isomerase, and ligase.
Claim 7
Dependent Claim 16 words
The method of claim 1, wherein the polynucleotide encodes components of a metabolic or biosynthetic pathway.
Claim 8
Independent Claim 285 words
A method for producing a polypeptide comprising: a) contacting a heterogenous, single-stranded DNA population containing complementary single-stranded DNA from at least one gene, wherein said single-stranded DNA is obtained by separating double-stranded DNA from at least one gene into two single strands, with one or more random oligonucleotide primers under conditions which allow annealing of the primers to the single-stranded heterogeneous DNA population; b) incubating the DNA of a) with a polymerase under conditions sufficient for DNA synthesis; c) contacting the DNA population with a means for interrupting polynucleotide synthesis, thereby resulting in synthesis of partially double-stranded DNA fragments; d) denaturing the resulting partially double-stranded DNA to produce a mixture of single-stranded DNA sequences, optionally separating the single-stranded DNA sequences into pools of single-stranded DNA sequences having various lengths, and further optionally subjecting the pools of single-stranded DNA sequences to a priming and amplification procedure to amplify one or more single-stranded sequences comprised of at least one of the pools of single-stranded DNA sequences; e) incubating a plurality of the single-stranded DNA sequences or at least one pool of the single-stranded DNA sequences under conditions which promote annealing of the single-stranded DNA sequences to other single-stranded DNA sequences at regions of shared homology and under conditions which promote synthesis of double-stranded DNA sequences, thereby resulting in double-stranded polynucleotides; and f) repeating b) through e) at least one time, wherein the double-stranded polynucleotides from e) are denatured prior to repeating b) through e); g) incorporating the double-stranded DNA of e) into an expression vector; h) introducing the expression vector of g) into a suitable host cell to form an expression library containing a plurality of clones; and i) screening the expression library for the desired polypeptide.
Claim 9
Independent Claim 285 words
A method for producing a polypeptide comprising: a) contacting a heterogenous, single-stranded DNA population containing complementary single-stranded DNA from at least one gene, wherein said single-stranded DNA is obtained by separating double-stranded DNA from at least one gene into two single strands, with one or more random oligonucleotide primers under conditions which allow annealing of the primers to the single-stranded heterogeneous DNA population; b) incubating the DNA of a) with a polymerase under conditions sufficient for DNA synthesis; c) contacting the DNA population with a means for interrupting polynucleotide synthesis, thereby resulting in synthesis of partially double-stranded DNA fragments; d) denaturing the resulting partially double-stranded DNA to produce a mixture of single-stranded DNA sequences, optionally separating the single-stranded DNA sequences into pools of single-stranded DNA sequences having various lengths, and further optionally subjecting the pools of single-stranded DNA sequences to a priming and amplification procedure to amplify one or more single-stranded sequences comprised of at least one of the pools of single-stranded DNA sequences; e) incubating a plurality of the single-stranded DNA sequences or at least one pool of the single-stranded DNA sequences under conditions which promote annealing of the single-stranded DNA sequences to other single-stranded DNA sequences at regions of shared homology and under conditions which promote synthesis of double-stranded DNA sequences, thereby resulting in double-stranded polynucleotides; and f) repeating b) through e) at least one time, wherein the double-stranded polynucleotides from e) are denatured prior to repeating b) through e); g) incorporating the double-stranded DNA of e) into an expression vector; h) introducing the expression vector of g) into a suitable host cell to form an expression library containing a plurality of clones; and i) screening the expression library for the desired polypeptide.
Claim 10
Dependent Claim 24 words
The method of claim 7, wherein the DNA population is contacted with a means for interrupting polynucleotide synthesis prior to or during part a).
Claim 11
Dependent Claim 24 words
The method of claim 7, wherein the DNA population is contacted with a means for interrupting polynucleotide synthesis prior to or during part b).
Claim 12
Dependent Claim 26 words
The method of claim 7, wherein the expression vector is selected from the group consisting of phage, plasmids, phagemids, cosmids, fosmids, viral vectors and artificial chromosomes.
Claim 13
Dependent Claim 26 words
The method of claim 7, wherein the host cell is selected from the group consisting of a bacterium fungus, plant cell, insect cell and animal cell.
Claim 14
Dependent Claim 89 words
The method as in claim 1 wherein said means for interrupting polynucleotide synthesis is selected from the group consisting of ethidium bromide, acridine orange, (+)-CC-1065, (+)-CC-1065-(N3-Adenine), a N-acetylated or deacetylated 4'-fluro-4-aminobiphenyl, N-acetylated or deacetylated 4-aminobiphenyl, trivalent chromium, a trivalent chromium salt, polycyclic aromatic hydrocarbon ("PAH"), 7-bromomethyl-benz(α)anthracene ("BMA"), tris(2,3-dibromopropyl)phosphate ("Tris-BP"), 1,2-dibromo-3-chloropropane ("DBCP"), 2-bromoacrolein (2BA), benzo(α)pyrene-7,8-dihydrodiol-9-10-epoxide ("BPDE"), platinum(II) halogen salt, N-hydroxy-2-amino-3-methylimidazo(4,5-f)-quinoline and N-hydroxy-2-amino-1-methyl-6-phenylimidazo(4,5-f)-pyridine, triple helix-forming agents, polymerase inhibitors, DNA binding proteins (SSB's), double-strand DNA binding proteins (DSB's), competing transcription polymerases, transcription activating factors (TAF's), histone, and UV, gamma or X-ray radiation.
Claim 15
Dependent Claim 89 words
The method as in claim 7, wherein said means for interrupting polynucleotide synthesis is selected from the group consisting of ethidium bromide, acridine orange, (+)-CC-1065, (+)-CC-1065-(N3-Adenine), a N-acetylated or deacetylated 4'-fluro-4-aminobiphenyl, N-acetylated or deacetylated 4-aminobiphenyl, trivalent chromium, a trivalent chromium salt, polycyclic aromatic hydrocarbon ("PAH"), 7-bromomethyl-benz(α)anthracene ("BMA"), tris(2,3-dibromopropyl)phosphate ("Tris-BP"), 1,2-dibromo-3-chloropropane ("DBCP"), 2-bromoacrolein (2BA), benzo(α)pyrene-7,8-dihydrodiol-9-10-epoxide ("BPDE"), platinum(II) halogen salt, N-hydroxy-2-amino-3-methylimidazo(4,5-f)-quinoline and N-hydroxy-2-amino-1-methyl-6-phenylimidazo(4,5-f)-pyridine, triple helix-forming agents, polymerase inhibitors, DNA binding proteins (SSB's), double-strand DNA binding proteins (DSB's), competing transcription polymerases, transcription activating factors (TAF's), histone, and UV, gamma or X-ray radiation.
Claim 16
Dependent Claim 236 words
An in vitro method for producing polynucleotides comprising: a) incubating a heterogenous, single-stranded DNA population containing complementary single-stranded DNA from at least one gene, wherein said single-stranded DNA is obtained by separating double-stranded DNA from at least one gene into two single strands, under conditions which allow annealing of the single-stranded DNA population at regions of homology; b) incubating the DNA of a) with a polymerase under conditions sufficient for DNA synthesis; c) contacting the DNA population with a means for interrupting polynucleotide synthesis, thereby resulting in synthesis of partially double-stranded DNA fragments; d) denaturing the resulting partially double-stranded DNA to produce a mixture of single-stranded DNA sequences, optionally separating the single-stranded DNA sequences into pools of single-stranded DNA sequences having various lengths, and further optionally subjecting the pools of single-stranded DNA sequences to a priming and amplification procedure to amplify one or more single-stranded sequences comprised of at least one of the pools of single-stranded DNA sequences; e) incubating a plurality of the single-stranded DNA sequences or at least one pool of the single-stranded DNA sequences under conditions which promote annealing of the single-stranded DNA sequences to other single-stranded DNA sequences at regions of shared homology and under conditions which promote synthesis of double-stranded DNA sequences, thereby resulting in double-stranded polynucleotides; and f) repeating b) through e) at least one time, wherein the double-stranded polynucleotides from e) are denatured prior to repeating b) through e).
Claim 17
Dependent Claim 236 words
An in vitro method for producing polynucleotides comprising: a) incubating a heterogenous, single-stranded DNA population containing complementary single-stranded DNA from at least one gene, wherein said single-stranded DNA is obtained by separating double-stranded DNA from at least one gene into two single strands, under conditions which allow annealing of the single-stranded DNA population at regions of homology; b) incubating the DNA of a) with a polymerase under conditions sufficient for DNA synthesis; c) contacting the DNA population with a means for interrupting polynucleotide synthesis, thereby resulting in synthesis of partially double-stranded DNA fragments; d) denaturing the resulting partially double-stranded DNA to produce a mixture of single-stranded DNA sequences, optionally separating the single-stranded DNA sequences into pools of single-stranded DNA sequences having various lengths, and further optionally subjecting the pools of single-stranded DNA sequences to a priming and amplification procedure to amplify one or more single-stranded sequences comprised of at least one of the pools of single-stranded DNA sequences; e) incubating a plurality of the single-stranded DNA sequences or at least one pool of the single-stranded DNA sequences under conditions which promote annealing of the single-stranded DNA sequences to other single-stranded DNA sequences at regions of shared homology and under conditions which promote synthesis of double-stranded DNA sequences, thereby resulting in double-stranded polynucleotides; and f) repeating b) through e) at least one time, wherein the double-stranded polynucleotides from e) are denatured prior to repeating b) through e).

References Cited (Backward Citations)

WO1991016427A1 Cited
WO1995017413A1 Cited
WO1995022625A1 Cited
US5605793A Cited
US5811238A Cited
US5830721A Cited
US5837458A Cited
WO1997035957A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2002-10-11 2003-04-12 2003-10-12 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2006-10-11 2007-04-12 2007-10-12 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2010-10-11 2011-04-12 2011-10-12 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag